1. Home
  2. MYNZ vs BDRX Comparison

MYNZ vs BDRX Comparison

Compare MYNZ & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYNZ
  • BDRX
  • Stock Information
  • Founded
  • MYNZ 2021
  • BDRX 2000
  • Country
  • MYNZ Germany
  • BDRX United Kingdom
  • Employees
  • MYNZ N/A
  • BDRX N/A
  • Industry
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYNZ Health Care
  • BDRX Health Care
  • Exchange
  • MYNZ Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • MYNZ 9.8M
  • BDRX 9.6M
  • IPO Year
  • MYNZ 2021
  • BDRX N/A
  • Fundamental
  • Price
  • MYNZ $0.48
  • BDRX $1.06
  • Analyst Decision
  • MYNZ Buy
  • BDRX Strong Buy
  • Analyst Count
  • MYNZ 2
  • BDRX 1
  • Target Price
  • MYNZ $3.00
  • BDRX $8.00
  • AVG Volume (30 Days)
  • MYNZ 1.3M
  • BDRX 3.5M
  • Earning Date
  • MYNZ 08-13-2024
  • BDRX 04-19-2024
  • Dividend Yield
  • MYNZ N/A
  • BDRX N/A
  • EPS Growth
  • MYNZ N/A
  • BDRX N/A
  • EPS
  • MYNZ N/A
  • BDRX N/A
  • Revenue
  • MYNZ $895,479.00
  • BDRX $482,278.00
  • Revenue This Year
  • MYNZ $67.40
  • BDRX N/A
  • Revenue Next Year
  • MYNZ $191.13
  • BDRX N/A
  • P/E Ratio
  • MYNZ N/A
  • BDRX N/A
  • Revenue Growth
  • MYNZ 69.00
  • BDRX N/A
  • 52 Week Low
  • MYNZ $0.32
  • BDRX $0.67
  • 52 Week High
  • MYNZ $4.90
  • BDRX $9.64
  • Technical
  • Relative Strength Index (RSI)
  • MYNZ 47.27
  • BDRX 55.78
  • Support Level
  • MYNZ $0.39
  • BDRX $0.71
  • Resistance Level
  • MYNZ $0.56
  • BDRX $1.66
  • Average True Range (ATR)
  • MYNZ 0.09
  • BDRX 0.12
  • MACD
  • MYNZ 0.02
  • BDRX 0.02
  • Stochastic Oscillator
  • MYNZ 66.45
  • BDRX 36.84

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Share on Social Networks: